SMAD3 and inflammatory bowel disease: This study demonstrates that TGF-β-related polymorphisms rs11545200 of LTBP3 and rs17293632 of SMAD3, both of which relate to the TGF-β signaling pathway, are associated with the clinical course of pediatric IBD.